Screening and Diagnosis of Sarcopenia
By Dr. Yi-Cheng Wu · Reviewed June 21, 2026
Sarcopenia is the age-related loss of muscle mass and function; it can be screened with questionnaires and calf circumference, then confirmed with muscle mass plus muscle strength or physical performance. Early detection can reduce risk.
Sarcopenia refers to the age-related loss of muscle mass and function. The Asian Working Group for Sarcopenia has proposed criteria suited to Asian populations: community-dwelling older adults can be screened with the SARC-F questionnaire, calf circumference (under 34 cm in men, under 33 cm in women), or SARC-CalF, and any single abnormal finding warrants further evaluation. Diagnosis requires muscle mass as a necessary condition, plus at least one of muscle strength (grip strength) or physical performance (6-metre walk, five-times sit-to-stand). Studies suggest that early screening helps reduce downstream risks such as falls and fractures.
The assessment pathway for screening and diagnosing sarcopenia
-
Start screening with the SARC-F questionnaire
Community-dwelling older adults can first use the SARC-F questionnaire for a quick assessment of sarcopenia risk. It covers five domains — strength, assistance in walking, rising from a chair, climbing stairs, and frequency of falls — and a score of 4 or higher warrants further evaluation.
-
Add calf circumference or SARC-CalF
Combine with a two-handed calf circumference measurement (under 34 cm in men, under 33 cm in women) or the SARC-CalF questionnaire (11 or higher) as simple indicators used alongside the questionnaire.
-
Any single abnormal finding warrants further evaluation
If any one of these screening indicators is abnormal, further complete evaluation is recommended; early detection helps reduce downstream risks such as falls and fractures.
-
Assess muscle strength (grip strength)
In the diagnostic phase, first assess grip strength as an indicator of muscle strength; the Smedley dynamometer is used standing with the elbow straight, while the Jamar dynamometer is used seated with the elbow bent to 90 degrees.
-
Assess physical performance
Use the 6-metre walk test and five-times sit-to-stand to assess physical performance, such as walking speed and lower-limb function.
-
Measure muscle mass
Assess limb muscle mass by body composition analysis or bone densitometry; limb lean mass can be regarded as limb muscle mass, then adjusted by height to derive an index.
-
Interpret using the combined criteria
Muscle mass is a necessary condition for diagnosis; adding at least one of muscle strength or physical performance allows a diagnosis of sarcopenia.
Sarcopenia is a concept first proposed by researchers in the 1980s, referring to the gradual loss of muscle mass with age. It was later recognized that not only muscle mass but also muscle function is affected. Countries around the world began studying this condition and formed research groups; among them, the Asian Working Group for Sarcopenia held several expert meetings and proposed diagnostic and screening criteria suited to Asian populations.
Thigh muscle strength declines by about 8% per decade after age 40 and by about 15% per decade after age 70. Sarcopenia shows up not only as reduced strength and declining muscle function, but may also involve poor physical fitness, reduced mobility, weight gain, and an increased risk of fractures.
The causes of sarcopenia can be divided into age-related causes and other secondary causes, including disease, low physical activity, or malnutrition.
Currently about 7 to 10% of adults over 65 in Taiwan have sarcopenia, estimated at around 300,000 people, but awareness of this condition is still low, because older-adult health issues have only drawn attention in recent years, and up to 80% of people are unaware they have sarcopenia.
The effects of sarcopenia are actually many and far more complex than most people imagine. The complications from falls, fractures, and being bedridden alone are troubling enough. Fortunately, with early screening and attention, many of the downstream chains of poor-health effects can be reduced.
Screening for sarcopenia
Self-assessment can be divided mainly into two settings: care facilities and community prevention.
People cared for in medical institutions or care facilities often have chronic diseases, limited mobility, or difficulty communicating, so they need to be assessed in different ways to identify the diseases and conditions below. Patients who use a wheelchair long-term or are bedridden are all high-risk, and even those with short-term mobility limitations who lack a rehabilitation or training plan warrant attention.
- Chronic diseases: heart failure, chronic obstructive pulmonary disease, diabetes, chronic kidney disease, and others
- Unintended weight loss
- Depressed mood
- Cognitive impairment
- Recurrent falls
- Malnutrition
For community-dwelling older adults, who mostly retain basic functional ability, the SARC-F questionnaire can quickly gauge whether a patient may have sarcopenia. Combined with calf circumference and the SARC-CalF questionnaire, any single abnormal finding leads to a recommendation for further evaluation.
The SARC-F screening tool is a quick, easy-to-use method for identifying patients at risk of sarcopenia. It was introduced by Dr. Malmstrom and Dr. Morley in 2013. The tool covers five main domains: strength, assistance in walking, rising from a chair, climbing stairs, and frequency of falls, and can quickly assess whether an individual is at risk of sarcopenia. Primary care providers should include SARC-F as part of their routine assessment, especially in older populations. When the SARC-F score is 4 or higher, additional assessments such as grip strength and gait speed can be performed.
- Calf circumference under 34 cm in men, under 33 cm in women
- Two-handed calf circumference measurement
- SARC-F questionnaire score of 4 or higher
- SARC-CalF questionnaire score of 11 or higher
Diagnosing sarcopenia
Diagnosis is based mainly on three components: muscle strength, physical performance, and muscle mass.
Muscle strength is assessed by grip strength. The Smedley dynamometer is used standing, with the elbow straight, while the Jamar dynamometer is used seated, with the elbow bent to 90 degrees.
Physical performance includes the 6-metre walk test and five-times sit-to-stand, and muscle mass is assessed by body composition analysis or bone densitometry.
Body composition analysis divides the body into three major parts: fat, lean, and bone. For assessing muscle mass, the focus is on limb muscle mass; because the limbs contain no visceral tissue, limb lean mass can be regarded as limb muscle mass.
For example, the lean mass of the left arm, right arm, left leg, and right leg is summed and converted to kilograms, then combined with the person’s height converted to metres, so an index can be calculated by formula.
At present, muscle mass is a necessary condition for diagnosing sarcopenia; adding at least one of muscle strength or physical performance allows a diagnosis of sarcopenia.
Summary
Sarcopenia is not something to fear; what is worrying is ignoring it.
Further reading
Frequently asked questions
How is sarcopenia screened?
Community-dwelling older adults can use the SARC-F questionnaire for a quick risk assessment, combined with calf circumference (under 34 cm in men, under 33 cm in women) or the SARC-CalF questionnaire. A SARC-F score of 4 or higher, a SARC-CalF score of 11 or higher, or a low calf circumference — any single abnormal finding — warrants further evaluation.
How is sarcopenia diagnosed?
Diagnosis is based mainly on three components: muscle strength, physical performance, and muscle mass. Muscle strength is assessed by grip strength; physical performance includes the 6-metre walk test and five-times sit-to-stand; and muscle mass is assessed by body composition analysis or bone densitometry to estimate limb muscle mass. Muscle mass is a necessary condition, and adding at least one of muscle strength or physical performance allows a diagnosis.
Why should sarcopenia be taken seriously?
Currently about 7 to 10% of adults over 65 in Taiwan have sarcopenia, yet up to 80% of them are unaware they have it. Sarcopenia can lead to consequences such as falls, fractures, and being bedridden, so early screening and attention help reduce a chain of downstream effects harmful to health.
This article is also available in the original Chinese, with the full reference list.
閱讀中文原文 · Read in Chinese